- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
All Names： Lenvatinib、Lenvima、乐伐替尼、仑伐替尼、乐卫玛
Indications：Suitable for adult patients who meet the corresponding diagnostic criteria, specifically for patients with locally recurrent or metastatic, progressive, radioactive iodine refractory differentiated thyroid cancer, advanced renal cell carcinoma patients (including those who have progressed after first-line treatment and previous anti angiogenic therapy), unresectable hepatocellular carcinoma patients, and advanced endometrial cancer patients who have been detected as pMMR or non MSI-H, have progressed with previous systemic therapy and are not suitable for radical surgery or radiotherapy.
Manufacturer：Daxiong
Customs Clearance Procedure：If the customs requires the package for customs clearance, please pay the customs clearance fee according to the content of EMS SMS and customs regulations.
Lenvatinib has also been approved for marketing in China for the treatment of radiation-induced iodine refractory differentiated thyroid cancer. At present, the drug has been included in the Chinese medical insurance catalog.
1、 Basic information of drugs
1. Drug name: Lenvatinib
2. Main ingredient: Lenvatinib
3. Specifications and properties: Capsule formulation, with specifications including 4mg and 10mg
2、 Indications, usage and dosage
1. Indications: Suitable for the treatment of BRAFV600 mutant advanced melanoma.
2. Usage and dosage: The specific usage and dosage should strictly follow the doctor's advice and cannot be adjusted by oneself.
3、 Medication precautions
1. Dosage: It is recommended to take it at a fixed time, and follow the doctor's advice before or after meals.
2. Handling of missed doses: If missed doses occur, do not take double the dosage and continue taking the next dose according to the usual schedule.
3. Vomiting treatment: If vomiting occurs after taking medication, it is not recommended to take it again and wait for the next regular medication time.
4、 Dose adjustment and special populations
1. Dose adjustment: Depending on patient tolerance and severity of adverse reactions, treatment may need to be interrupted, reduced, or permanently discontinued.
2. Special populations: Pregnant women, lactating women, and individuals with liver and kidney dysfunction should use under the guidance of a doctor.
5、 Adverse reactions
Common adverse reactions include diarrhea, photosensitivity, nausea, fever, vomiting, etc. Laboratory tests may reveal abnormal conditions such as elevated GGT and elevated phosphocreatine kinase.
6、 Taboos and Interactions
1. Contraindications: Do not use for individuals who are allergic to any of the ingredients in this product.
2. Drug interactions: There may be interactions when used in combination with other drugs, and the doctor should be informed of all drugs being used.
7、 Storage and production information
Storage method: Store at room temperature, avoid moisture and direct sunlight.
Lenvatinibinformation
